Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 août 2019 16h05 HE | Source: Eyenovia, Inc.

Eyenovia Reports Second Quarter 2019 Financial Results

NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
06 août 2019 08h30 HE | Source: Eyenovia, Inc.

Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results

NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
16 juil. 2019 16h05 HE | Source: Eyenovia, Inc.

Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering

NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
15 juil. 2019 16h30 HE | Source: Eyenovia, Inc.

Eyenovia, Inc. Announces Closing of Public Offering

NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
11 juil. 2019 09h00 HE | Source: Eyenovia, Inc.

Eyenovia, Inc. Prices Public Offering of Common Stock

NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
10 juil. 2019 16h07 HE | Source: Eyenovia, Inc.

Eyenovia, Inc. Announces Proposed Public Offering of Common Stock

NEW YORK, July 10, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
04 juin 2019 08h30 HE | Source: Eyenovia, Inc.

Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia

NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
14 mai 2019 06h30 HE | Source: Eyenovia, Inc.

Eyenovia Reports First Quarter 2019 Financial Results

NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
06 mai 2019 08h30 HE | Source: Eyenovia, Inc.

Eyenovia Announces Presentation of Successful Phase 3 Studies at the ASCRS-ASOA Annual Meeting

NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
01 mai 2019 08h30 HE | Source: Eyenovia, Inc.

Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results

NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...

Page précédente